PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver cirrhosis |
| Symptom | |infection |
| Sentences | 71 |
| PubMedID- 23437095 | Firstly reported an account of a patient suffering a g. hollisae infection who presented with liver cirrhosis and hepatic encephalopathy in 1982 . |
| PubMedID- 24996883 | Those patients with chronic hcv infection are at risk of developing liver cirrhosis and/or hepatocellular carcinoma.1 much effort has aready been invested in understanding the factors that determine the differing outcomes in individuals but disentangling the impact of host and viral factors has been difficult. |
| PubMedID- 22844502 | Hepatitis b virus (hbv), a member of the hepadnavirus family, is the main pathogen for human viral hepatitis; chronic infection can lead to liver cirrhosis and hepatocellular carcinoma 1. |
| PubMedID- 24265844 | In up to 80% of infected patients, hcv established persistent infection, often leading to liver cirrhosis and hepatocellular carcinoma . |
| PubMedID- 19853065 | Hepatitis c virus (hcv) currently infects an estimated 170 million individuals worldwide; in approximately 80% of these cases, the virus establishes a chronic infection that leads to liver cirrhosis and hepatocellular carcinoma 1. |
| PubMedID- 24612987 | Conclusions: this study failed to demonstrate a difference between n and t-s groups in their effects on preventing infection in patients with liver cirrhosis. |
| PubMedID- 25506280 | Chronic hepatitis b virus (hbv) infection may lead to liver cirrhosis, chronic liver disease, and liver cancer. |
| PubMedID- 20924213 | Acute kidney injury is frequently observed in patients with liver cirrhosis, and is associated with infection, the use of diuretics, reduced effective circulating volume and hepatorenal syndrome.1 in cirrhotic patients, acute kidney injury is particularly dangerous because it poses an obstacle to treatment and has a direct correlation to mortality. |
| PubMedID- 23216853 | Background: gastrointestinal dysmotility may be involved in the development of bacterial translocation and infection in patients with liver cirrhosis. |
| PubMedID- 22163345 | The majority progress to chronic infection, which ultimately leads to liver cirrhosis and hepatocellular carcinoma, both leading causes of liver transplantation (lt) . |
| PubMedID- 22977309 | Treatment guidelines recommend treating hbv infection before the development of liver cirrhosis based on viral load and serum alanine aminotransferase levels.4,5 this approach can significantly delay, or even reverse, the progression of disease and is clearly more cost effective than waiting to initiate treatment only at the onset of serious illness.11,33 however, early treatment is often not possible as it is estimated that 65% of the hbv-infected population in the us are unaware of their infection, meaning that initial diagnosis frequently occurs at a late stage of disease progression, when symptoms of decompensated cirrhosis are apparent.2 despite the preferential outcomes of early treatment, it is still beneficial to treat hbv with decompensated cirrhosis, as demonstrated in the etv-048 study. |
| PubMedID- 24593285 | Hcv infection can lead to liver cirrhosis, hepatocellular carcinoma and death. |
| PubMedID- 22337948 | Hepatitis c virus (hcv) is a globally distributed pathogen that infects 3% of the world's population.1 persistent infection may be associated with liver cirrhosis, hepatocellular cancer and death.2 hcv exhibits a high degree of genetic diversity and may be classified by phylogenetic analysis into seven major genotypes that share sequence homology of approximately 80% at the amino acid (aa) level and numerous subtypes.3 phylogenetic analysis has shown that hcv has existed in human hosts for thousands of years, resulting in particular genotypes that are endemic in distinct geographical locations.4 however, over the last 100 years a number of distinct strains, in particular subtypes 1a, 1b and 3a, have become globally distributed in an epidemic that is associated with medical practice and intravenous drug use. |
| PubMedID- 21927665 | Previously, it has been discovered that hcv infection in absence of liver cirrhosis can induce insulin resistance and liver iron deposition and tnf-alpha was introduced as culprit mechanisms.33,34 in our study on thalassemic patients, serum glucose was not different between various grades of liver siderosis, but it significantly correlated with serum ferritin. |
| PubMedID- 23642259 | Some epidemiological studies have reported an association of t. gondii infection with liver cirrhosis. |
| PubMedID- 24635883 | As hcv infection may lead to liver cirrhosis , more studies are required to ascertain this pathological link between hcv infection, socs1 methylation and hcc progression. |
| PubMedID- 23635509 | Conclusions: both splenectomy and partial spleen artery embolization could be beneficial for low-dose peg-ifna-2a plus rbv antiviral therapy for early decompensated liver cirrhosis patients with chronic hcv infection and would not influence antiviral efficacy. |
| PubMedID- 25843699 | Objective: to evaluate the usefulness of procalcitonin (pct) for diagnosing infection in patients with liver cirrhosis admitted to an intensive care unit. |
| PubMedID- 21637332 | The most remarkable feature of this blood-borne virus is its ability to evade host immunity, resulting in over 80% of infected individuals developing chronic infection that is associated with liver cirrhosis and hepatocellular carcinoma – thus becoming a leading cause for liver transplantation 1. |
| PubMedID- 26214477 | In liver cirrhosis with bacterial infection, hepatoadrenal syndrome has been described recently as a progressive impairment in the adrenocortical reserve, with deficient production or action of glucocorticoids resulting in adrenal insufficiency. |
| PubMedID- 26314548 | Hepatitis c virus (hcv) infection often leads to chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. |
Page: 1 2